{{Rsnum
|rsid=353644
|Gene=CD44
|Chromosome=11
|position=35160066
|Orientation=minus
|GMAF=0.4835
|Gene_s=CD44
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 35.4 | 46.0 | 18.6
| HCB | 46.0 | 46.0 | 8.0
| JPT | 49.6 | 38.9 | 11.5
| YRI | 3.4 | 26.5 | 70.1
| ASW | 7.0 | 36.8 | 56.1
| CHB | 46.0 | 46.0 | 8.0
| CHD | 51.4 | 40.4 | 8.3
| GIH | 37.6 | 40.6 | 21.8
| LWK | 1.8 | 27.5 | 70.6
| MEX | 8.6 | 60.3 | 31.0
| MKK | 3.2 | 30.1 | 66.7
| TSI | 32.4 | 44.1 | 23.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=22205660
|Title=Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine
|OA=1
}}

{{PMID|20806065|OA=1
}} Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}